ArticleBreast cancer (Dove Medical Press)2022

Real-World Outcome and Prognostic Factors Among HER2-Positive Metastatic Breast Cancer Patients Receiving Pyrotinib-Based Therapy: A Multicenter Retrospective Analysis.

Jing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.